Abbott Infinity First Brain Stimulator to Target GPi to Treat Parkinson’s

Abbott has announced that the FDA has given the company the first ever approval for a device to treat Parkinson’s by delivering deep brain stimulation (DBS) to the internal globus pallidus (GPi), an area associated with motor function. The Infinity DBS system, originally developed by St. Jude Medical that became part of Abbott, already h (Read more...)

Full Story →